US clinical stage biotech Rapport Therapeutics (Nasdaq: RAPP) has announced the appointment of Dr Jeffrey Sevigny as chief ...

Rapport Therapeutics (RAPP) announced the appointment of Dr. Jeffrey Sevigny as chief medical officer, CMO, effective immediately. Dr. Sevigny ...

Medtronic (NYSE: MDT) announced results from a registry highlighting the effectiveness of the Prevail drug-coated balloon ...

Dr. Sevigny, a seasoned leader in drug development, brings over 15 years of experience to the role, having previously served as CMO at Prevail Therapeutics (NASDAQ:PRVL) and senior vice president ...